Magazine article Nutrition Action Healthletter

Lost Lives, Bogus Claims

Magazine article Nutrition Action Healthletter

Lost Lives, Bogus Claims

Article excerpt

You can set your clock by it. Whenever the nation is beset by some new health scourge, the charlatans emerge with their miraculous cures.

Ebola, H1N1 flu, West Nile Virus. They all spawned products promising to inoculate the healthy or cure the infected.

The Food and Drug Administration, as it should have, warned the manufacturers of those products that their treatments and "vaccines" were unapproved.

It's time to expand that fraternity of frauds to include the manufacturers of bogus opioid-addiction cures.

The opioid epidemic prematurely snuffs out the lives of more than 30,000 Americans each year. The FDA has approved three drugs to treat opioid addiction: methadone, buprenorphine, and naltrexone.

While only about 20 percent of people with an addiction are in treatment, any new treatment would be invaluable.

Make that any new effective treatment.

That means scratching the supplements made by the eight companies contacted by David Schardt for his article on page 11 ("The Opioid-Scam Epidemic").

Despite making claims like "helps ease withdrawal symptoms" and "speed detox," the companies produced no adequate evidence that their pills worked. Worse yet, some didn't even feel that they needed to.

"Scientific studies are very costly, so no, there is no study," acknowledged one manufacturer.

In December, the Center for Science in the Public Interest, Nutrition Action's publisher, asked the FDA to ban the opioid-withdrawal supplements made by the eight companies, and asked the Federal Trade Commission to prohibit the companies from using phony claims in their advertisements. …

Search by... Author
Show... All Results Primary Sources Peer-reviewed

Oops!

An unknown error has occurred. Please click the button below to reload the page. If the problem persists, please try again in a little while.